Junior Resident.
Additional Professor Department of Internal Medicine; Corresponding Author.
J Assoc Physicians India. 2022 Dec;70(12):11-12. doi: 10.5005/japi-11001-0160.
The current guidelines on diagnosis and management of new-onset seizures in stroke are not well defined, especially in the Indian setting. Our study aims at providing insight into the hospital prevalence risk of new-onset seizures following ischemic stroke and to correlate seizure risk with the characteristics of stroke and other clinical parameters.
A total of 127 patients were analyzed for the study where we assessed the clinical severity and the imaging severity of stroke using the National Institute of Health Stroke Scale (NIHSS) score and Alberta Stroke Program Early CT (ASPECT) score, respectively. Seizure-related variables including semiology, timing, and details of antiepileptic drugs (AEDs) were assessed under the domain of early and late poststroke seizures (PSSs). All patients were followed for 6 months for the seizure recurrence and change in Barthel index. In statistical analysis, quantitative variables were compared using the independent t-test/Mann-Whitney U test, and qualitative variables were correlated using Chi-square test/Fisher's exact test. Univariate and multivariate logistic regression was used to find out the significant risk factors of acute symptomatic seizure.
The mean age of the study population was 59.72 years (±14.77), with a male predominance (60.63%). About 78.74% of the cases had an NIHSS score more than or equal to 6.24% had posterior circulation strokes and the rest had anterior circulation strokes. A cortical location of infarct was observed in 62.2% of cases and a subcortical location in 61.4% of cases. The prevalence of early PSSs observed in our study was 10.6%. Of those, 80% had generalized seizures, 13.3% had focal seizures, and 6.67% had focal seizures with secondary generalizations. No patient in the study group had late-onset seizures. Total leukocyte count, serum protein levels, serum uric acid levels, and erythrocyte sedimentation rate (ESR) values were associated with early seizures (p<0.05). Patients with early seizures were found to have a longer hospital stay (8 vs 6 days with p<0.05). In the Trial of Org 10,172 in Acute Stroke Treatment (TOAST) etiological classification, an acute stroke of undetermined etiology was found to have a significant association with the occurrence of early seizure in both univariate and multivariate analysis [p = 0.030; odds ratio (OR) 4.735 (1.160-22.576)]. There was no difference in change in the Barthel index among the two groups.
There was no recurrence of seizures in those who defaulted for AED and one patient had a seizure even on AED. Prophylactic AEDs in stroke patients based on stroke characteristics could not be ascertained, but the sample size was small. Knowing the fact that antiepileptics cause sedation and increase the chance of aspiration, continuing AEDs in patients who develop acute symptomatic seizures should be judged judiciously.
目前关于中风后新发癫痫的诊断和管理指南尚不完善,特别是在印度。我们的研究旨在深入了解缺血性中风后新发癫痫的医院患病率风险,并将癫痫风险与中风特征和其他临床参数相关联。
对 127 例患者进行了研究,我们使用国立卫生研究院中风量表(NIHSS)评分和阿尔伯塔中风项目早期 CT(ASPECT)评分分别评估中风的临床严重程度和影像严重程度。在早期和晚期中风后癫痫发作(PSS)领域评估了与癫痫发作相关的变量,包括症状学、发作时间和抗癫痫药物(AED)的详细信息。所有患者均在 6 个月内进行随访,以了解癫痫复发和巴氏指数的变化。在统计分析中,使用独立 t 检验/曼-惠特尼 U 检验比较定量变量,使用卡方检验/ Fisher 确切检验比较定性变量。使用单变量和多变量逻辑回归来找出急性症状性癫痫发作的显著危险因素。
研究人群的平均年龄为 59.72 岁(±14.77),男性居多(60.63%)。大约 78.74%的病例 NIHSS 评分≥6,2.24%的病例为后循环中风,其余为前循环中风。梗死部位在皮质的病例占 62.2%,在皮质下的病例占 61.4%。我们研究中观察到的早期 PSS 患病率为 10.6%。其中,80%的患者有全身性癫痫发作,13.3%的患者有局灶性癫痫发作,6.67%的患者有局灶性癫痫发作继发全身性发作。研究组中无患者发生迟发性癫痫发作。总白细胞计数、血清蛋白水平、血尿酸水平和红细胞沉降率(ESR)值与早期癫痫发作有关(p<0.05)。与早期癫痫发作相关的患者住院时间更长(8 天与 6 天,p<0.05)。在组织 10,172 急性卒中治疗(TOAST)病因分类的试验中,急性病因不明的中风在单变量和多变量分析中均与早期癫痫发作有显著相关性[ p = 0.030;优势比(OR)4.735(1.160-22.576)]。两组之间的巴氏指数变化无差异。
未服用 AED 的患者中未发生癫痫复发,而有 1 例患者即使服用 AED 也发生了癫痫发作。基于中风特征,不能确定在中风患者中预防性使用 AED,但样本量较小。鉴于抗癫痫药会引起镇静并增加吸入的机会,对于发生急性症状性癫痫发作的患者,继续使用 AED 应慎重判断。